CG - Cell Generation

At Cell Generation (CG), we supply high-quality human blood-derived cells — including PBMCs, leukopaks, and immune cell subsets — for both research and clinical use. We support companies and institutions advancing cell and gene therapies, immuno-oncology, and translational research by providing ethically sourced, IRB-approved material from healthy and patient donors. All collections are performed under strict quality protocols, with full traceability, documentation, and donor recallability. Our capabilities include: • Fresh and cryopreserved PBMCs from healthy and disease-state donors • Mobilized PBMCs and leukopaks (G-CSF, plerixafor, or combination protocols) • Enriched subpopulations: CD3, CD4, CD8, CD14, CD19, CD34, CD56, and more • Clinical-use materials with robust QC, documentation, and regulatory support • Custom collections and processing aligned to your protocols and timelines • Disease-specific material: oncology, autoimmune, infectious diseases, etc. We bring deep experience in applied and translational research as well as clinical trials. Whether you’re optimizing a manufacturing workflow or sourcing cells for an IND-enabling study, CG offers reliability, flexibility, and scientific partnership. We are happy to build with you — and for you — a product tailored to your size, scope, and requirements. From donor selection to processing protocols and documentation, Cell Generation is here to make your cell sourcing faster, smoother, and more precise. Cell Generation — powering progress from research to therapy.